Medicare Enrolled

Dr. Mark Pomaranski, M.D.

MOHS-Micrographic Surgery Physician · Traverse City, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
550 MUNSON AVE, SUITE 200, Traverse City, MI 49686
2319358717
In practice since 2006 (19 years)
NPI: 1962511097 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pomaranski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pomaranski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pomaranski

Dr. Mark Pomaranski is a mohs-micrographic surgery physician in Traverse City, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pomaranski performed 1,055 Medicare services across 882 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pomaranski received a total of $1,416 from 19 pharmaceutical and/or device companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pomaranski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 1,055 Medicare services $1,416 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,055
Medicare services
Bottom 20% in MI for mohs-micrographic surgery physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
882
Unique beneficiaries
$259
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~56 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Skin growth removal and lab exam, 1-5 blocks
This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory.
321 $472 $1,343
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks 252 $315 $803
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
186 $40 $81
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
129 $77 $202
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
70 $61 $135
Complicated wound repair, 2.6-7.5 cm
A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet.
27 $182 $979
Skin growth removal and lab exam, 1-5 blocks
A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination.
23 $437 $1,228
Additional tissue block examination
Microscopic examination of an additional tissue block beyond the initial five. This step is performed to analyze extra samples from the same growth.
23 $61 $159
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
12 $195 $469
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm 12 $134 $685
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,416
Total received (2018-2024)
Avg $202/year across 7 years
Bottom 45% in MI for mohs-micrographic surgery physician
19
Companies
74
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,416 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$347
2023
$280
2022
$122
2021
$238
2020
$162
2019
$200
2018
$66

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$116
Novartis Pharmaceuticals Corporation
$75
Lilly USA, LLC
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
GENZYME CORPORATION
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 73.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$433
Janssen Biotech, Inc.
$143
ABBVIE INC.
$116
Lilly USA, LLC
$109
AbbVie Inc.
$90
Regeneron Healthcare Solutions, Inc.
$79
PruGen, Inc. Pharmaceuticals
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Sun Pharmaceutical Industries Inc.
$45
GENZYME CORPORATION
$44
Incyte Corporation
$42
DERMIRA, INC.
$37
SUN PHARMACEUTICAL INDUSTRIES INC.
$33
AbbVie, Inc.
$30
Smith+Nephew, Inc.
$25
Kyowa Kirin, Inc.
$23
Medtronic, Inc.
$19
Galderma Laboratories, L.P.
$13
Helsinn Therapeutics (U.S.), Inc.
$12
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
CLOSUREFAST · COSENTYX · DUPIXENT · EPIDUO FORTE · HUMIRA · Humira · ILUMYA · Ilumya · LIBTAYO · OPZELURA · POTELIGEO · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Santyl · TALTZ · TREMFYA · Tremfya · VALCHLOR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a mohs-micrographic surgery physician in Traverse City?
Compare mohs-micrographic surgery physicians in the Traverse City area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

Mohs-micrographic surgery physicians within 10 mi
2
Per 100K population
2.1
County median income
$79,486
Nearest hospital
MUNSON MEDICAL CENTER
9.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pomaranski is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pomaranski experienced with skin growth removal and lab exam, 1-5 blocks?
Based on Medicare claims data, Dr. Pomaranski performed 321 skin growth removal and lab exam, 1-5 blocks services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pomaranski receive payments from pharmaceutical companies?
Yes. Dr. Pomaranski received a total of $1,416 from 19 companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pomaranski's costs compare to other mohs-micrographic surgery physicians in Traverse City?
Dr. Pomaranski's average Medicare payment per service is $259. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pomaranski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →